abstract |
The present invention relates to the treatment of compound formula (I), their preparations, and autoimmune disorders, organ transplant rejection, activated immune system related disorders, and other disorders modulated by lymphopenia or S1P receptors. For their use as pharmaceutically active immunosuppressive agents. |